Search

everythinglearnresearchcommunity

for

Search:↓

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

The patient with lupus and hair loss improved with oral and topical minoxidil.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Topical finasteride helps regrow hair and reduce balding without side effects.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

A small percentage of minoxidil users may develop an allergic skin reaction.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Severe and early hair loss may indicate a higher risk of heart disease.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Combining conventional and integrative treatments can help reduce hair loss and improve hair growth in women with androgenic alopecia.

Sublingual minoxidil is safe and well-tolerated for hair loss treatment.

Sublingual minoxidil is a safe and effective treatment for hair loss, especially in women.

Minoxidil is more effective than finasteride for treating hair loss in women aged 20 to 50 in Colombia.

Low-dose oral minoxidil effectively treats male pattern baldness.

Polymeric nanoparticles with dutasteride may effectively treat hair loss by targeting hair follicles.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

Iontophoresis and chitosan microparticles improve minoxidil delivery for hair loss treatment.

Females with androgenic alopecia have significantly lower vitamin D3 and ferritin levels.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Platelet-rich plasma (PRP) is a cheap and easy treatment for hair loss, but not suitable for everyone. It also helps in healing ulcers, rejuvenating skin, and improving hair transplants.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Flutamide and its metabolite can effectively reduce androgen effects.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.